← FDA Drug Approvals (Drugs@FDA)
SILIQ
BLA · Biologics License Application · Sponsor: VALEANT LUXEMBOURG · Approved 2017-02-15
Drug application
- FDA Application #
BLA761032- Application type
- Biologics License Application
- Brand name
- SILIQ
- Generic name
- BRODALUMAB
- Active ingredients
- BRODALUMAB
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- VALEANT LUXEMBOURG
- Manufacturer
- Bausch Health US LLC
- First approval
- 2017-02-15
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown